Here are the S-3 shelf registrations from enGene Therapeutics Inc. Warrants (ENGNW) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow ENGNW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ENGNW filings page.
enGene Holdings Inc. is registering an aggregate of $400,000,000 of securities under a shelf registration, which includes $150,500,276.03 of unsold securities previously registered under File No. 333-283201 pursuant to Rule 415(a)(6).
The prospectus lists the securities that may be offered from time to time — common shares, preferred shares, debt securities, subscription receipts, warrants and units — and states specific terms will be provided in prospectus supplements.